28 results on '"Sande, Charles J."'
Search Results
2. The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine development
3. Vaccination against Respiratory Syncytial Virus
4. Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effects
5. Airway response to respiratory syncytial virus has incidental antibacterial effects
6. Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics
7. Development of a controlled human infection model to study respiratory syncytial virus infection in older adults
8. Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia
9. Genetic Relatedness of Infecting and Reinfecting Respiratory Syncytial Virus Strains Identified in a Birth Cohort From Rural Kenya
10. Implementation strategies for passive respiratory syncytial virus immunisation
11. Priorities for developing respiratory syncytial virus vaccines in different target populations
12. In-silico immune cell deconvolution of the airway proteomes of infants with pneumonia reveals a link between reduced airway eosinophils and an increased risk of mortality
13. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
14. Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya.
15. Respiratory syncytial virus: diagnosis, prevention and management
16. Comprehensive profiling of antibodies against multiple infectious diseases in serum and the airway mucosa using synthetic peptide-based linear epitope microarrays
17. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection
18. Development of respiratory syncytial virus (RSV) vaccines for infants
19. Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya
20. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
21. Best practice in the prevention and management of paediatric respiratory syncytial virus infection
22. RSV vaccine use – the missing data
23. Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
24. RSV vaccine use – the missing data.
25. Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia
26. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
27. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
28. Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.